{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:29:06Z","timestamp":1793694546889,"version":"4.5.1"},"reference-count":201,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2025\/014\/T1\/Seed-Sep24\/04"],"award-info":[{"award-number":["NUHSRO\/2025\/014\/T1\/Seed-Sep24\/04"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/F\/22\/34174"],"award-info":[{"award-number":["FS\/F\/22\/34174"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000327","name":"Heart Research UK","doi-asserted-by":"publisher","award":["PHD22-100003"],"award-info":[{"award-number":["PHD22-100003"]}],"id":[{"id":"10.13039\/501100000327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011744","name":"National University Health System","doi-asserted-by":"publisher","award":["NUHSRO\/2025\/028\/Startup\/04"],"award-info":[{"award-number":["NUHSRO\/2025\/028\/Startup\/04"]}],"id":[{"id":"10.13039\/501100011744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["22855"],"award-info":[{"award-number":["22855"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.109655","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:13:11Z","timestamp":1790694791000},"page":"109655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Resolution of inflammation: A novel therapeutic paradigm for rheumatoid arthritis and its comorbidities"],"prefix":"10.1016","volume":"233","author":[{"given":"Roshanak Fekri","family":"Yazdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6425-5911","authenticated-orcid":false,"given":"Sze Ian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1782-1942","authenticated-orcid":false,"given":"Brian Basto","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8891-1356","authenticated-orcid":false,"given":"Ashton Juin Kai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6098-9381","authenticated-orcid":false,"given":"Hong Yong","family":"Peh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-0857","authenticated-orcid":false,"given":"Jianmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.109655_bib1","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","author":"Finckh","year":"2022","journal-title":"Nat. Rev. Rheumatol. 18"},{"key":"10.1016\/j.phrs.2026.109655_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.101477","article-title":"The epidemiology of established rheumatoid arthritis","volume":"33","author":"Ot\u00f3n","year":"2019","journal-title":"Best. Pract. & Res. Clin. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00508-024-02392-8","article-title":"Genetic relationship between rheumatoid arthritis and cardiovascular diseases: a systematic review of Mendelian randomization studies","volume":"137","author":"Ausserwinkler","year":"2025","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.phrs.2026.109655_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41927-025-00572-1","article-title":"Global prevalence of metabolic syndrome in patients with Rheumatoid arthritis: a systematic review and meta-analysis","volume":"9","author":"Jafari","year":"2025","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2024.105790","article-title":"2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis","volume":"91","author":"Fautrel","year":"2024","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.phrs.2026.109655_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.12968\/bjcn.2022.27.5.232","article-title":"The prevalence of comorbidity in rheumatoid arthritis: a systematic review and meta-analysis","volume":"27","author":"Hill","year":"2022","journal-title":"Br. J. Community Nurs."},{"key":"10.1016\/j.phrs.2026.109655_bib7","article-title":"Prevalence of nonalcoholic fatty liver disease in rheumatoid arthritis: An updated systematic review and meta-analysis","volume":"104","author":"Mahapatro","year":"2025","journal-title":"Med. (Baltim. )"},{"issue":"11","key":"10.1016\/j.phrs.2026.109655_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2024.0341","article-title":"Osteoporosis and rheumatoid arthritis: a review of current understanding and practice","volume":"85","author":"Kirkham-Wilson","year":"2024","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib9","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.80634","article-title":"Infection risk in biological disease-modifying anti-rheumatic drugs","author":"Isa","year":"2025","journal-title":"Cureus 17"},{"key":"10.1016\/j.phrs.2026.109655_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108753","article-title":"Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation","volume":"265","author":"Peh","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2026.109655_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2133.2012.11177.x","article-title":"Efficacy and safety of 15(R\/S)-methyl-lipoxin A4 in topical treatment of infantile eczema","volume":"168","author":"Wu","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.phrs.2026.109655_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103896","article-title":"Specialized pro-resolving mediators and autoimmunity: recent insights and future perspectives","volume":"24","author":"Vomero","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2026.109655_bib13","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2026.109655_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis & Rheum. Off. J. Am. Coll. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib15","article-title":"Disease mechanisms in preclinical rheumatoid arthritis: a narrative review","volume":"9","author":"Rom\u00e3o","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.phrs.2026.109655_bib16","doi-asserted-by":"crossref","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.phrs.2026.109655_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis & Rheum. Off. J. Am. Coll. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178546","article-title":"Association of Human Leukocyte Antigen (HLA) class II (DRB1 and DQB1) alleles and haplotypes with Rheumatoid Arthritis in Sudanese patients","volume":"14","author":"Ali","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib19","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1007\/s10067-025-07590-x","article-title":"Integrative GWAS and Mendelian randomization study of rheumatoid arthritis based on the 2019 UK Biobank questionnaire","volume":"44","author":"Cai","year":"2025","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nri.2016.124","article-title":"The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting","volume":"17","author":"Malmstr\u00f6m","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.689698","article-title":"Etiology and risk factors for rheumatoid arthritis: a state-of-the-art review","volume":"8","author":"Rom\u00e3o","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12016-012-8346-7","article-title":"Genetics of rheumatoid arthritis \u2014 a comprehensive review","volume":"45","author":"Kurk\u00f3","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.31138\/mjr.301223.eaf","article-title":"Epidemiology and risk factors for rheumatoid arthritis development","volume":"34","author":"Venetsanopoulou","year":"2023","journal-title":"Mediterr. J. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard-2022-223134","article-title":"Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking","volume":"82","author":"Tang","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08958378.2025.2542555","article-title":"Modeling environmental inhalant exposure in rheumatoid arthritis","volume":"37","author":"de Ocampo","year":"2025","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.phrs.2026.109655_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1221125","article-title":"Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention","volume":"14","author":"Maisha","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109655_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/annrheumdis-2021-221386","article-title":"Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA","volume":"81","author":"Martinsson","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib30","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbagrm.2013.07.003","article-title":"Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis","volume":"1829","author":"Wang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2026.109655_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fimmu.2015.00192","article-title":"Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis","volume":"6","author":"Pruijn","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41467-017-02763-y","article-title":"T cells specific for post-translational modifications escape intrathymic tolerance induction","volume":"9","author":"Raposo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.109655_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001228","article-title":"Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"7","author":"Catrina","year":"2021","journal-title":"RMD Open."},{"key":"10.1016\/j.phrs.2026.109655_bib34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","article-title":"V.M. Holers, Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis","volume":"116","author":"Kuhn","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2026.109655_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/25785826.2023.2220931","article-title":"Osteoclast differentiation in rheumatoid arthritis","volume":"47","author":"Yokota","year":"2024","journal-title":"Immunol. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ard.2026.01.023","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update","volume":"85","author":"Smolen","year":"2026","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib38","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/acsptsci.4c00067","article-title":"Unveiling novel drug targets and emerging therapies for rheumatoid arthritis: a comprehensive review","volume":"7","author":"Khokhar","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.phrs.2026.109655_bib39","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"del Rinc\u00f3n","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib40","doi-asserted-by":"crossref","unstructured":"N. Budtarad, J. Prawjaeng, P. Leelahavarong, S. Pilasant, C. Chanjam, P. Narongroeknawin, T. Kitumnuaypong, W. Katchamart, Efficacy and safety of biologic, biosimilars and targeted synthetic DMARDs in moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: a systematic review and network meta-analysis, (2023) 2023.01.20.23284852. https:\/\/doi.org\/10.1101\/2023.01.20.23284852.","DOI":"10.1101\/2023.01.20.23284852"},{"key":"10.1016\/j.phrs.2026.109655_bib41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s40265-024-02059-8","article-title":"Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs","volume":"84","author":"Favalli","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2026.109655_bib42","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/cells10040881","article-title":"Cardiac dysfunction in rheumatoid arthritis: the role of inflammation","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.109655_bib44","article-title":"Cardiovascular risk associated with TNF alpha inhibitor use in patients with rheumatoid arthritis","author":"Hussain","year":"2021","journal-title":"Cureus 13"},{"key":"10.1016\/j.phrs.2026.109655_bib45","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.3390\/jcm12237265","article-title":"Associations between rheumatoid arthritis and various comorbid conditions in germany\u2014a retrospective cohort study","volume":"12","author":"Imanuel","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rdc.2013.10.005","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"40","author":"Sen","year":"2014","journal-title":"Rheum. Dis. Clin. North. Am."},{"key":"10.1016\/j.phrs.2026.109655_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101999","article-title":"Accelerated atherosclerosis and management of cardiovascular risk in autoimmune rheumatic diseases: an updated review","volume":"48","author":"Karakasis","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.phrs.2026.109655_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/20503121251330171","article-title":"Interplay of rheumatoid arthritis and cardiovascular disease: Insights and prospects","volume":"13","author":"Poznyak","year":"2025","journal-title":"SAGE Open. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/acr.20382","article-title":"Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis","volume":"63","author":"Monaco","year":"2011","journal-title":"Arthritis Care & Res."},{"key":"10.1016\/j.phrs.2026.109655_bib50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2796.2009.02209.x","article-title":"Weak associations between human leucocyte antigen genotype and acute myocardial infarction","volume":"268","author":"Bj\u00f6rkbacka","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.01.024","article-title":"Proinflammatory HLA-DRB1* 01-haplotype predisposes to ST-elevation myocardial infarction","volume":"221","author":"Paakkanen","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2026.109655_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-0039.2006.00735.x","article-title":"Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease","volume":"69","author":"Palikhe","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.phrs.2026.109655_bib53","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/art.1780400615","article-title":"Expansion of unusual CD4+ T cells in severe rheumatoid arthritis","volume":"40","author":"Martens","year":"1997","journal-title":"Arthritis & Rheum. Off. J. Am. Coll. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib54","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/01.CIR.0000131450.66017.B3","article-title":"CD4+ CD28\u2212 T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients","volume":"109","author":"Gerli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.109655_bib55","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/hc0502.103348","article-title":"T-cell\u2013mediated lysis of endothelial cells in acute coronary syndromes","volume":"105","author":"Nakajima","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.109655_bib56","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cvr\/cvaa202","article-title":"Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome","volume":"117","author":"Bullenkamp","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.109655_bib57","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/acr.25481","article-title":"Risk of Incident Heart Failure and Heart Failure Subtypes in Patients With Rheumatoid Arthritis","volume":"77","author":"Kawano","year":"2025","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.phrs.2026.109655_bib58","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/01.CIR.0000097109.90783.FC","article-title":"Inflammatory markers and onset of cardiovascular events: results from the Health ABC study","volume":"108","author":"Cesari","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.109655_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jhh.2011.113","article-title":"Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women","volume":"27","author":"Masiha","year":"2013","journal-title":"J. Human. Hypertens."},{"key":"10.1016\/j.phrs.2026.109655_bib60","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study","volume":"107","author":"Vasan","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.109655_bib61","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.109655_bib62","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/ard.2009.124362","article-title":"Increased prevalence of diastolic dysfunction in rheumatoid arthritis","volume":"69","author":"Liang","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib63","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ard.2006.053710","article-title":"Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis","volume":"66","author":"Maradit-Kremers","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib64","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3899\/jrheum.100979","article-title":"The influence of rheumatoid arthritis disease characteristics on heart failure","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.hfc.2013.10.003","article-title":"Cardiovascular comorbidity in rheumatic diseases a focus on heart failure","volume":"10","author":"Wright","year":"2014","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.phrs.2026.109655_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrcardio.2017.118","article-title":"Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases","volume":"15","author":"Bartoloni","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2026.109655_bib67","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mcna.2016.08.004","article-title":"Oxidative stress and hypertensive diseases","volume":"101","author":"Loperena","year":"2016","journal-title":"Med. Clin. North. Am."},{"key":"10.1016\/j.phrs.2026.109655_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: Extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2026.109655_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09059180.00008014","article-title":"Rheumatoid arthritis-associated lung disease","volume":"24","author":"Shaw","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.phrs.2026.109655_bib70","doi-asserted-by":"crossref","first-page":"14509","DOI":"10.3390\/ijms241914509","article-title":"Etiology and pathogenesis of rheumatoid arthritis-interstitial lung disease","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109655_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.837133","article-title":"Interstitial lung disease in rheumatoid arthritis: a practical review","volume":"9","author":"Laria","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4078\/jrd.2022.29.2.61","article-title":"Recent advances in basic and clinical aspects of rheumatoid arthritis-associated interstitial lung diseases","volume":"29","author":"Lee","year":"2022","journal-title":"J. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1577180","article-title":"Rheumatoid arthritis and chronic obstructive pulmonary disease in US adults: a cross-sectional analysis","volume":"12","author":"Mi","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib74","first-page":"639","article-title":"Rheumatoid arthritis and risk of chronic obstructive pulmonary disease or asthma among women: a marginal structural model analysis in the Nurses\u2019 Health Study","author":"Sparks","year":"2018","journal-title":"Elsevier"},{"key":"10.1016\/j.phrs.2026.109655_bib75","article-title":"Bidirectional association between rheumatoid arthritis and chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib76","first-page":"968","article-title":"Patients with asthma have a higher risk of rheumatoid arthritis: A systematic review and meta-analysis","author":"Charoenngam","year":"2020","journal-title":"Elsevier"},{"key":"10.1016\/j.phrs.2026.109655_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1006290","article-title":"Association of rheumatoid arthritis with bronchial asthma and asthma-related comorbidities: a population-based national surveillance study","volume":"10","author":"Kim","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib78","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4046\/trd.2017.80.2.113","article-title":"Asthma and the risk of rheumatoid arthritis: an insight into the heterogeneity and phenotypes of asthma","volume":"80","author":"Rolfes","year":"2017","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib79","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2026.109655_bib80","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib81","first-page":"551","article-title":"Inflammatory status and insulin resistance","volume":"5","author":"Grimble","year":"2002","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.phrs.2026.109655_bib82","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109655_bib83","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11926-012-0271-5","article-title":"Cardiovascular disease and rheumatoid arthritis: an update","volume":"14","author":"Charles-Schoeman","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.phrs.2026.109655_bib84","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/acr.25537","article-title":"Metabolic consequences of rheumatoid arthritis","volume":"77","author":"Barry","year":"2025","journal-title":"Arthritis Care & Res."},{"key":"10.1016\/j.phrs.2026.109655_bib85","article-title":"Crossing the metabolic homeostasis divide: panoramic decoding of therapeutic targets for metabolic-inflammatory crosstalk in rheumatoid arthritis","volume":"16","author":"Liang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1659541","article-title":"Metabolic reprogramming: the central mechanism driving inflammatory polarization in rheumatoid arthritis and the regulatory role of traditional Chinese medicine","volume":"16","author":"Wen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib87","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2025.2590267","article-title":"Liver\u2013joint axis: Hepatitis B virus as a contributor to rheumatoid arthritis pathogenesis","volume":"16","author":"Wu","year":"2025","journal-title":"Virulence"},{"key":"10.1016\/j.phrs.2026.109655_bib88","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1038\/s41598-025-91898-w","article-title":"Rheumatoid arthritis and risk of pancreatitis: a nationwide cohort study","volume":"15","author":"Park","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.109655_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41444","article-title":"Contradictory mechanisms of rheumatoid arthritis and hepatitis B virus infection activation","volume":"11","author":"Zhu","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.phrs.2026.109655_bib90","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s41927-025-00513-y","article-title":"Association between hepatitis C virus infection and rheumatoid arthritis: a nationwide cross-sectional study","volume":"9","author":"Tang","year":"2025","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib91","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/medicina58111637","article-title":"Depression in rheumatoid arthritis: a narrative review\u2014diagnostic challenges, pathogenic mechanisms and effects","volume":"58","author":"Ionescu","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.phrs.2026.109655_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.992223","article-title":"Research progress on rheumatoid arthritis-associated depression","volume":"16","author":"Liu","year":"2023","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.phrs.2026.109655_bib93","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrrheum.2016.112","article-title":"Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways","volume":"12","author":"Sturgeon","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib94","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib95","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: a new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.phrs.2026.109655_bib96","first-page":"587","article-title":"Leukotriene synthesis by epithelial cells","volume":"18","author":"Luo","year":"2003","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.phrs.2026.109655_bib97","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and Inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2026.109655_bib98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109655_bib99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib100","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400610R","article-title":"15-epi-lipoxin A5 promotes neutrophil exit from exudates for clearance by splenic macrophages","volume":"38","author":"Peh","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2026.109655_bib101","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100097","article-title":"Resolution Pharmacology: State-of-the-art and therapeutic landscape","volume":"77","author":"Perretti","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2026.109655_bib103","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.4049\/jimmunol.1402645","article-title":"Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects","volume":"194","author":"Montero-Melendez","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib104","article-title":"AP1189: A Novel Oral Biased Melanocortin Agonist with Anti-inflammatory and Pro-resolving Effect for the Treatment of Rheumatoid Arthritis [abstract]","author":"Jonassen","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1599109","article-title":"High CBD extract (CBD-X) modulates inflammation and immune cell activity in rheumatoid arthritis","volume":"16","author":"Aswad","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.949407","article-title":"Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-\u03baB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms","volume":"14","author":"Saraiva-Santos","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib107","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/annrheumdis-2018-213511","article-title":"Maresin 1 improves the Treg\/Th17 imbalance in rheumatoid arthritis through miR-21","volume":"77","author":"Jin","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib108","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.4049\/jimmunol.1502268","article-title":"Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation","volume":"197","author":"Arnardottir","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib109","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85922","article-title":"Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis","volume":"1","author":"Norling","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2026.109655_bib110","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1038\/s41467-021-26516-0","article-title":"Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy","volume":"12","author":"Dort","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.109655_bib111","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96530-1","article-title":"Effect of resolvin D5 on T cell differentiation and osteoclastogenesis analyzed by lipid mediator profiling in the experimental arthritis","volume":"11","author":"Yamada","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.109655_bib112","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1476-5381.2009.00483.x","article-title":"Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics","volume":"158","author":"Perretti","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.109655_bib113","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020385118","article-title":"Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis","volume":"118","author":"Chen","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2026.109655_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2012.00028","article-title":"Annexin A1 N-Terminal Derived Peptide Ac2-26 Exerts Chemokinetic Effects on Human Neutrophils","volume":"3","author":"Dalli","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.109655_bib115","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/art.20201","article-title":"Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis","volume":"50","author":"Yang","year":"2004","journal-title":"Arthritis & Rheum."},{"key":"10.1016\/j.phrs.2026.109655_bib116","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.4049\/jimmunol.1203000","article-title":"Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2\/lipoxin A4 receptor","volume":"190","author":"Dalli","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib117","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000097087","article-title":"The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats","volume":"1","author":"Ceriani","year":"1994","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.phrs.2026.109655_bib118","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/CS20120461","article-title":"Angiotensin-(1\u20137): beyond the cardio-renal actions","volume":"124","author":"Passos-Silva","year":"2012","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.phrs.2026.109655_bib119","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.1021\/acs.jmedchem.9b02101","article-title":"Discovery of BMS-986235\/LAR-1219: a potent formyl peptide receptor 2 (FPR2) selective agonist for the prevention of heart failure","volume":"63","author":"Asahina","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2026.109655_bib120","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s44321-025-00227-1","article-title":"Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis","volume":"17","author":"Margraf","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib121","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.intimp.2018.05.028","article-title":"Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis","volume":"61","author":"Odobasic","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.109655_bib122","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-pharmtox-051921-085407","article-title":"Lipoxin Mimetics and the Resolution of Inflammation","volume":"63","author":"Godson","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2026.109655_bib123","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/art.43268","article-title":"Efferocytosis and Its Role in Rheumatic Diseases","volume":"77","author":"Tang","year":"2025","journal-title":"Arthritis & Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.635102","article-title":"Insights Into Leukocyte Trafficking in Inflammatory Arthritis \u2013 Imaging the Joint","volume":"9","author":"Manning","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.phrs.2026.109655_bib125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fimmu.2016.00430","article-title":"Ectopic lymphoid structures: powerhouse of autoimmunity","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib126","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbalip.2012.07.011","article-title":"Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC\u2013MS\/MS","volume":"1821","author":"Giera","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Biology Lipids"},{"key":"10.1016\/j.phrs.2026.109655_bib127","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","article-title":"Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis","volume":"26","author":"Alivernini","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib128","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.imlet.2020.08.006","article-title":"Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis","volume":"227","author":"\u00d6zg\u00fcl \u00d6zdemir","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.phrs.2026.109655_bib129","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.plefa.2016.03.004","article-title":"Specialised pro-resolving mediators of inflammation in inflammatory arthritis","volume":"107","author":"Barden","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.phrs.2026.109655_bib130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrrheum.2010.105","article-title":"Rheumatoid cachexia and cardiovascular disease","volume":"6","author":"Summers","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib131","doi-asserted-by":"crossref","first-page":"44","DOI":"10.22540\/JFSF-08-044","article-title":"Sarcopenia in rheumatoid arthritis. A narrative review","volume":"8","author":"Moschou","year":"2023","journal-title":"J. Frailty Sarcopenia Falls"},{"key":"10.1016\/j.phrs.2026.109655_bib132","doi-asserted-by":"crossref","DOI":"10.1186\/ar2717","article-title":"Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids","volume":"11","author":"Gheorghe","year":"2009","journal-title":"Arthritis Res. & Ther."},{"key":"10.1016\/j.phrs.2026.109655_bib133","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2026.109655_bib134","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-019-1852-8","article-title":"vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis","volume":"21","author":"Benabdoun","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2026.109655_bib135","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00296-011-1984-x","article-title":"Disturbed Th17\/Treg balance in patients with rheumatoid arthritis","volume":"32","author":"Niu","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.phrs.2026.109655_bib136","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/annrheumdis-2013-204145","article-title":"Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use","volume":"74","author":"Proudman","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib137","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"F. D\u2019acquisto, Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"Perretti","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib138","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-pharmtox-051821-042743","article-title":"Resolution pharmacology: focus on pro-resolving annexin A1 and lipid mediators for therapeutic innovation in inflammation","volume":"63","author":"Perretti","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2026.109655_bib139","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8239258","article-title":"Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance","volume":"2016","author":"Sugimoto","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2026.109655_bib140","first-page":"e60","article-title":"Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.phrs.2026.109655_bib141","doi-asserted-by":"crossref","DOI":"10.1155\/MI\/2006\/73835","article-title":"Regulation of Annexin I in Rheumatoid Synovial Cells by Glucocorticoids and Interleukin-1","volume":"2006","author":"Morand","year":"2006","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.phrs.2026.109655_bib142","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4049\/jimmunol.1202236","article-title":"Deficiency of Annexin A1 in CD4+ T Cells Exacerbates T Cell\u2013Dependent Inflammation","volume":"190","author":"Yang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib143","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrrheum.2013.126","article-title":"Annexin A1: potential for glucocorticoid sparing in RA","volume":"9","author":"Yang","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib144","first-page":"483","article-title":"Targeting the resolution pathway of inflammation using Ac2-26 peptide-loaded PEGylated lipid nanoparticles for the remission of rheumatoid arthritis","volume":"16","author":"Qin","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2026.109655_bib145","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1681\/ASN.2016101066","article-title":"Immunologic Effects of the Renin-Angiotensin System","volume":"28","author":"Crowley","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2026.109655_bib146","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147819","article-title":"Angiotensin-(1-7)\/MasR axis promotes migration of monocytes\/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis","volume":"7","author":"Zaidan","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2026.109655_bib147","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","article-title":"Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis","volume":"185","author":"da Silveira","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib148","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3389\/fimmu.2017.01596","article-title":"Angiotensin-(1-7) promotes resolution of neutrophilic inflammation in a model of antigen-induced arthritis in mice","volume":"8","author":"Barroso","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.56.1.1","article-title":"Targeting melanocortin receptors as a novel strategy to control inflammation","volume":"56","author":"Catania","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2026.109655_bib150","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-eular.128","article-title":"SP0128 The Melanocortin Anti-Inflammatory Paradigm","volume":"72","author":"Perretti","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.109655_bib151","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.10526","article-title":"Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis","volume":"46","author":"Getting","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2026.109655_bib152","doi-asserted-by":"crossref","first-page":"E1181","DOI":"10.1152\/ajpendo.00412.2002","article-title":"\u03b1-Melanocyte-stimulating hormone is a novel regulator of bone","volume":"284","author":"Cornish","year":"2003","journal-title":"Am. J. Physiol. -Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2026.109655_bib153","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/246856","article-title":"The Alpha-Melanocyte Stimulating Hormone Induces Conversion of Effector T Cells into Treg Cells","volume":"2011","author":"Taylor","year":"2011","journal-title":"J. Transplant."},{"key":"10.1016\/j.phrs.2026.109655_bib154","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41467-020-14421-x","article-title":"Therapeutic senescence via GPCR activation in synovial fibroblasts facilitates resolution of arthritis","volume":"11","author":"Montero-Melendez","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.109655_bib155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11926-011-0163-0","article-title":"Role of melanocortin receptors in the regulation of gouty inflammation","volume":"13","author":"Montero-Melendez","year":"2011","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.phrs.2026.109655_bib156","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jacbts.2021.07.007","article-title":"Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction","volume":"6","author":"Garc\u00eda","year":"2021","journal-title":"JACC Basic Translational Science"},{"key":"10.1016\/j.phrs.2026.109655_bib157","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1111\/bph.12768","article-title":"A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis","volume":"171","author":"Kao","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.109655_bib158","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/jm900592h","article-title":"6-Methyl-2,4-Disubstituted Pyridazin-3(2H)-ones: A Novel Class of Small-Molecule Agonists for Formyl Peptide Receptors","volume":"52","author":"Cilibrizzi","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2026.109655_bib159","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14232","article-title":"Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice","volume":"8","author":"Qin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.109655_bib160","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/cvr\/cvae103","article-title":"Novel formylpeptide receptor 1\/2 agonist limits hypertension-induced cardiovascular damage","volume":"120","author":"Singh","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.109655_bib161","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejmech.2018.10.049","article-title":"Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)","volume":"162","author":"de Gaetano","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2026.109655_bib162","article-title":"The BEGIN Study: A Double-blind, Multi-center, Two-part, Randomized, Placebo-controlled Study of the Safety, Tolerability, and Efficacy of 4 Weeks of Treatment with AP1189 in Early Rheumatoid Arthritis (RA) Patients with Active Joint Disease","author":"Jonassen","year":"2022","journal-title":"ACR Meet. Abstr. Arthritis Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib163","article-title":"Efficacy and Safety of the Biased Melanocortin Receptor Agonist AP1189\/resomelagon in Combination with Methotrexate in DMARD-na\u00efve Rheumatoid Arthritis Patients: The EXPAND Trial","author":"Bihlet","year":"2024","journal-title":"ACR Meet. Abstr. Arthritis Rheumatol."},{"key":"10.1016\/j.phrs.2026.109655_bib164","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40744-019-00189-0","article-title":"Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis","volume":"7","author":"DeMizio","year":"2020","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.phrs.2026.109655_bib165","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.82269","article-title":"Cardiovascular Outcomes of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Review of the Current Evidence","author":"Sunkara","year":"2025","journal-title":"Cureus 17"},{"key":"10.1016\/j.phrs.2026.109655_bib166","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12859","article-title":"An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques","volume":"7","author":"Fredman","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.109655_bib167","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.01057.2009","article-title":"Resolvin E1 protects the rat heart against reperfusion injury","volume":"299","author":"Keyes","year":"2010","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2026.109655_bib168","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301802R","article-title":"The pro-resolving mediator, annexin A1 regulates blood pressure, and age-associated changes in cardiovascular function and remodeling","volume":"38","author":"Singh","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2026.109655_bib169","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1096\/fj.99-0602fje","article-title":"Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment","volume":"14","author":"D\u2019Amico","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2026.109655_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107005","article-title":"The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation","volume":"198","author":"Chen","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.109655_bib171","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/all.15920","article-title":"Resolvin D2 regulates type 2 inflammatory responses and promotes resolution of mouse allergic inflammation","volume":"79","author":"Peh","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.phrs.2026.109655_bib172","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2147\/JAA.S402326","article-title":"Asthma Prevalence and Phenotyping in the General Population: The LEAD (Lung, hEart, sociAl, boDy) Study","volume":"16","author":"Schiffers","year":"2023","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.phrs.2026.109655_bib173","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186889","article-title":"Cellular and molecular features of asthma mucus plugs provide clues about their formation and persistence","volume":"135","author":"Liegeois","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2026.109655_bib174","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4187\/respcare.10873","article-title":"Understanding COPD Etiology, Pathophysiology, and Definition","volume":"68","author":"Curtis","year":"2023","journal-title":"Respir. Care"},{"key":"10.1016\/j.phrs.2026.109655_bib175","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.freeradbiomed.2017.06.023","article-title":"Vitamin E isoform \u03b3-tocotrienol protects against emphysema in cigarette smoke-induced COPD","volume":"110","author":"Peh","year":"2017","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib176","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2026.109655_bib177","doi-asserted-by":"crossref","first-page":"L888","DOI":"10.1152\/ajplung.00125.2015","article-title":"Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages","volume":"309","author":"Croasdell","year":"2015","journal-title":"Am. J. Physiol. -Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.phrs.2026.109655_bib178","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00950-2023","article-title":"Dysregulation of lipid mediators in patients with frequent exacerbations of COPD","volume":"11","author":"Fisk","year":"2025","journal-title":"ERJ Open. Res."},{"key":"10.1016\/j.phrs.2026.109655_bib179","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","article-title":"Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness","volume":"178","author":"Levy","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib180","article-title":"Impact of pharmacological and non-pharmacological interventions on mortality in chronic obstructive pulmonary disease (COPD) patients","volume":"84","author":"Zysman","year":"2023","journal-title":"Respir. Med. Res."},{"key":"10.1016\/j.phrs.2026.109655_bib181","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1039\/D1FO03551G","article-title":"N-3 PUFAs and their specialized pro-resolving lipid mediators on airway inflammatory response: beneficial effects in the prevention and treatment of respiratory diseases","volume":"13","author":"Z\u00fa\u00f1iga-Hern\u00e1ndez","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2026.109655_bib182","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2019.09.028","article-title":"Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes","volume":"145","author":"Levy","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib183","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058258","article-title":"A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation","volume":"8","author":"Hsiao","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.phrs.2026.109655_bib184","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.phrs.2026.109655_bib185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2172-12-59","article-title":"Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis","volume":"12","author":"Damazo","year":"2011","journal-title":"BMC Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib186","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13487","article-title":"The regulation of efferocytosis signaling pathways and adipose tissue homeostasis in physiological conditions and obesity: Current understanding and treatment options","volume":"23","author":"Tajbakhsh","year":"2022","journal-title":"Obes. Rev."},{"key":"10.1016\/j.phrs.2026.109655_bib187","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.4049\/jimmunol.1201272","article-title":"Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat","volume":"189","author":"Cl\u00e0ria","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib188","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75353-6","article-title":"The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery","volume":"10","author":"Schulte","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.109655_bib189","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1254753","article-title":"Dyslipidemia in rheumatoid arthritis: the possible mechanisms","volume":"14","author":"Yan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib190","first-page":"430","article-title":"Adiponectin: an adipokine with protective features against metabolic syndrome","volume":"18","author":"Esfahani","year":"2015","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"10.1016\/j.phrs.2026.109655_bib191","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/ijms27010535","article-title":"Inflammation and Resolution in Obesity-Related Cardiovascular Disease","volume":"27","author":"Karakasis","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109655_bib192","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2015.05.003","article-title":"Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease","volume":"22","author":"B\u00f6rgeson","year":"2015","journal-title":"Cell. Metab."},{"key":"10.1016\/j.phrs.2026.109655_bib193","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/pr.109.001578","article-title":"International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family","volume":"61","author":"YE","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2026.109655_bib194","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1096\/fj.201902172R","article-title":"The Annexin A1\/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia","volume":"34","author":"Machado","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2026.109655_bib195","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.109655_bib196","doi-asserted-by":"crossref","first-page":"18685","DOI":"10.1073\/pnas.1410938111","article-title":"Nonredundant protective properties of FPR2\/ALX in polymicrobial murine sepsis","volume":"111","author":"Gobbetti","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.109655_bib197","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3389\/fimmu.2020.02080","article-title":"RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial Clearance","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109655_bib198","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1021\/jasms.4c00211","article-title":"Development and Validation of Methodologies for the Identification of Specialized Pro-Resolving Lipid Mediators and Classic Eicosanoids in Biological Matrices","volume":"35","author":"Dooley","year":"2024","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"10.1016\/j.phrs.2026.109655_bib199","doi-asserted-by":"crossref","first-page":"eadw1245","DOI":"10.1126\/scisignal.adw1245","article-title":"Technical recommendations for analyzing oxylipins by liquid chromatography\u2013mass spectrometry","volume":"18","author":"Schebb","year":"2025","journal-title":"Sci. Signal."},{"key":"10.1016\/j.phrs.2026.109655_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2026.101075","article-title":"Validated bioanalysis of oxylipins confirms specialized pro-resolving mediator formation in vitro and in vivo","volume":"67","author":"Hofstetter","year":"2026","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2026.109655_bib201","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/s41467-020-19176-z","article-title":"Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis","volume":"11","author":"Gomez","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826015707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826015707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:05:39Z","timestamp":1793693139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826015707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":201,"alternative-id":["S1043661826015707"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109655","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resolution of inflammation: A novel therapeutic paradigm for rheumatoid arthritis and its comorbidities","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109655"}}